Oral mucositis: an inflammation of mucous membranes in the mouth, which usually appears as red, ulcer-like sores1,2
In patients being treated for cancer, likelihood of experiencing OM varies by tumor type and treatment regimen.
By tumor type
By targeted therapy
Additional targeted therapeutics associated with risk of OM include bevacizumab, cetuximab, erlotinib, gefitinib, and sorafenib.11
OM continues to be a problem for patients undergoing treatment for cancer.1,12 Management of OM should be considered for patients who face OM associated with treatment of cancer.1,12,13
The WHO Oral Toxicity Scale
The WHO (World Health Organization) classification of oral toxicity combines descriptions of mucosal changes, pain, and functionality into a single composite score.1,14,15
Help patients learn more about oral mucositis. Download the Oral Mucositis Overview for Patients here.